| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,379 |
1,661 |
$519K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,292 |
2,610 |
$490K |
| G0378 |
Hospital observation service, per hour |
477 |
303 |
$245K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,836 |
1,532 |
$181K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,299 |
3,552 |
$166K |
| 71046 |
Radiologic examination, chest; 2 views |
2,056 |
1,508 |
$149K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
415 |
317 |
$131K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,377 |
2,848 |
$129K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,214 |
493 |
$109K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
149 |
133 |
$92K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,569 |
1,048 |
$91K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
813 |
558 |
$80K |
| 80053 |
Comprehensive metabolic panel |
8,690 |
5,727 |
$76K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,426 |
1,459 |
$73K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
157 |
111 |
$70K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
964 |
852 |
$66K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,679 |
2,873 |
$57K |
| 86328 |
|
1,951 |
1,508 |
$52K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,246 |
1,803 |
$49K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,494 |
1,131 |
$48K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,465 |
1,941 |
$48K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
704 |
368 |
$45K |
| 36415 |
Collection of venous blood by venipuncture |
16,227 |
7,544 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,474 |
5,617 |
$38K |
| 70450 |
Computed tomography, head or brain; without contrast material |
132 |
89 |
$37K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,314 |
1,874 |
$31K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,519 |
984 |
$30K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,898 |
2,112 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,535 |
2,240 |
$29K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,090 |
968 |
$29K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
366 |
325 |
$21K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,192 |
723 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
591 |
508 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
46 |
38 |
$16K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
49 |
42 |
$16K |
| 96376 |
|
202 |
82 |
$16K |
| 80061 |
Lipid panel |
1,694 |
1,427 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,033 |
834 |
$12K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
675 |
580 |
$11K |
| 87634 |
|
230 |
208 |
$11K |
| 80305 |
|
1,234 |
997 |
$10K |
| 43249 |
|
17 |
12 |
$10K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
603 |
460 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
76 |
65 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
12 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
149 |
128 |
$8K |
| 84439 |
|
1,218 |
1,070 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,323 |
1,147 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
202 |
65 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,315 |
1,064 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
369 |
289 |
$7K |
| 81001 |
|
2,217 |
1,879 |
$6K |
| 84484 |
|
538 |
412 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
530 |
354 |
$6K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
74 |
73 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
723 |
611 |
$6K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
55 |
52 |
$5K |
| 81003 |
|
1,970 |
1,384 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
367 |
327 |
$5K |
| 81025 |
|
606 |
531 |
$4K |
| 82607 |
|
361 |
326 |
$4K |
| 87481 |
|
48 |
21 |
$4K |
| 83690 |
|
599 |
500 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
33 |
30 |
$3K |
| 83735 |
|
642 |
550 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
500 |
354 |
$2K |
| 82728 |
|
180 |
165 |
$2K |
| 83880 |
|
65 |
53 |
$2K |
| 87486 |
|
66 |
57 |
$2K |
| 87581 |
|
66 |
57 |
$2K |
| 83605 |
|
186 |
154 |
$2K |
| 82553 |
|
164 |
135 |
$1K |
| 83550 |
|
247 |
224 |
$1K |
| 86738 |
|
81 |
74 |
$1K |
| 83540 |
|
298 |
260 |
$1K |
| 87807 |
|
141 |
130 |
$1K |
| 87077 |
|
248 |
187 |
$1K |
| 73030 |
|
14 |
12 |
$1K |
| 82550 |
|
221 |
179 |
$1K |
| 82150 |
|
219 |
184 |
$976.59 |
| 0011A |
|
65 |
65 |
$893.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
45 |
41 |
$868.26 |
| 71045 |
Radiologic examination, chest; single view |
14 |
14 |
$858.11 |
| 73630 |
|
14 |
12 |
$836.88 |
| 85610 |
|
191 |
150 |
$798.71 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
17 |
12 |
$762.70 |
| 85652 |
|
120 |
92 |
$667.84 |
| 87640 |
|
23 |
20 |
$619.01 |
| 87653 |
|
24 |
21 |
$548.08 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
66 |
37 |
$546.62 |
| 87541 |
|
17 |
15 |
$464.90 |
| 87186 |
|
86 |
58 |
$420.64 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
25 |
14 |
$347.22 |
| 93246 |
|
12 |
12 |
$329.03 |
| 0012A |
|
19 |
19 |
$240.00 |
| 80306 |
|
12 |
12 |
$115.39 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
13 |
$106.75 |
| 85730 |
|
18 |
12 |
$68.81 |
| 86308 |
|
13 |
12 |
$42.70 |